A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

News

Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.

Date of publication : 21/08/2018

Le Projet MiMédi

MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

Au sein de ce consortium, Diaclone apporte son expertise et son savoir-faire de plus de 30 ans dans le domaine des anticorps, afin d’aider à la mise en place de processus novateur en matière de tri cellulaire, de détection de contamination, de suivi de populations cellulaires, etc…

    

 

Pour plus d'information cliquez ici

  • AIS LOGO
    7th Antibody Industrial Symposium 2019
    Date of publication : 23/04/2019



    Diaclone and the mAbexperts group will be present at the 7th Antibody Industrial Symposium 2019 (AIS 2019)  “Harnessing the immune system with therapeutic antibodies” jointly...

    Read more
  • IL-17
    DIACLONE Assays for the Human IL-17 Family
    Date of publication : 23/04/2019

    DIACLONE has developed one of the largest ranges of ELISA and ELISpot kits available for the detection of Human IL-17A, IL-17F and IL-17A/F:




    Human IL-17A ELISpot...

    Read more
  • Prod cell
    NEW! RD-Biotech supplier of murine monoclonal antibody D1-25, for the quantification of rabies virus by ELISA.
    Date of publication : 08/04/2019

    Signature of a license agreement with Institut Pasteur - France: RD-Biotech becomes the supplier of the clone D1-25 (anti-rabies virus monoclonal antibody)


    PRODUCT SPECIFICATIONS:
    - Clone:...

    Read more
  • QVQ joins the Biotech Investissement Group
    Date of publication : 12/10/2018

    Dear Customers and Partners

    We are pleased to announce that QVQ, a company based in Utrecht (The Netherlands), is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (Biotech...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more